Varenicline for smoking cessation and reduction in people with severe mental illnesses: systematic review and meta-analysis
Uloženo v:
Wu, Q., et al., Varenicline for smoking cessation and reduction in people with severe mental illnesses: systematic review and meta-analysis. Addiction, vol. 111, n. 9, 2016, p. 1554-1567.
Ref.
515465
Umístění:
SIIS R.696 / SIIS Archivo (R.696)
Palabras clave:
Drogodependencias, Enfermedades mentales, Tabaquismo, Diagnóstico dual, Efectos, Tratamiento médico, Fármacos, Efectos, Resultados, Evaluación de servicios, Literatura científica
Drogodependencias, Enfermedades mentales, Tabaquismo, Diagnóstico dual, Efectos, Tratamiento médico, Fármacos, Efectos, Resultados, Evaluación de servicios, Literatura científica
Podobné jednotky: Varenicline for smoking cessation and reduction in people with severe mental illnesses: systematic review and meta-analysis
- Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis
- Effect of smoking reduction therapy on smoking cessation for smokers without an intention to quit: an updated systematic review and meta-analysis of randomized controlled
- A mixed-method systematic review and meta-analysis of mental health professionals' attitudes toward smoking and smoking cessation among people with mental illnesses
- Past major depression and smoking cessation outcome: a systematic review and meta-analysis update
- Prescribing of smoking cessation medication in England since the introduction of varenicline
- Effectiveness of varenicline as an aid to smoking cessation in primary care: an observational study